Fig. 1.
Fig. 1. Treatment with 20 mg/kg busulfan is nonmyeloablative in sickle mice. / (A) Average absolute neutrophil count (ANC, from automated complete blood count analysis) of 10 sickle mice treated with 20 mg/kg busulfan. (B) Platelet count (from automated complete blood count analysis) of 10 sickle mice treated with 20 mg/kg busulfan.

Treatment with 20 mg/kg busulfan is nonmyeloablative in sickle mice.

(A) Average absolute neutrophil count (ANC, from automated complete blood count analysis) of 10 sickle mice treated with 20 mg/kg busulfan. (B) Platelet count (from automated complete blood count analysis) of 10 sickle mice treated with 20 mg/kg busulfan.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal